Elizabeth Iorns
Scientific Founder & Advisor @ Transcripta Bio
Palo Alto, United States
Elizabeth Iorns is a seed investor at Transcripta Bio in Palo Alto focused on Software and SaaS. Elizabeth Iorns is the Co-Founder, President, and CEO of Science Exchange. She previously worked at Y Combinator as a Part-time partner. Elizabeth Iorns attended the University of Auckland.
- Total investments:
- 6
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Elizabeth Iorns invests in
Stages Elizabeth Iorns invests in
Countries Elizabeth Iorns invests in
Round sizes
Round size
- Seed
- $1.9M–$3M
Investment Focus
Industry
- Software 3 (50%)
- SaaS 2 (33%)
- Health Care 2 (33%)
- Health Diagnostics 2 (33%)
- Energy 1 (17%)
Stage
- Seed 5 (83%)
- Pre-Seed 1 (17%)
Country
- United States 3 (50%)
- Canada 1 (17%)
- Mexico 1 (17%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Unima
|
Unima is decentralizing rapid testing across industries by taking diagnostics out of the lab to the place these are needed the most to secure a timely diagnostic for everyone, anywhere.Unima is solving is the centralization of lab testing, which limits the access to a timely diagnostic for billions. Current technology for diagnostics is veryprecise and can detect almost any disease known, but the problem is these require labs with expensive equipment and specialized technicians making lab testing impossible to scale up to provide universal and timely access to diagnostics.To solve this problem Unima developed Find, a rapid testing technology platform for real time diagnostics which allows anyone to diagnose a disease directly where it is needed, without using lab equipment, with results in 15 minutes or less and at a very low cost. With Find anyone can have access to a timely diagnostic even in the most remote areas of the world.The Find platform uses shark antibodies modified with genetic engineering to detect disease biomarkers in blood, saliva, urine or water samples. These shark antibodies are used in microfluidic cards and generate a visual reactions when in contact with specific biomarkers of the disease to be tested. Then to evaluate the result of the test, a picture of the testing card is taken with the proprietary Xplora smartphone app which runs image analysis process and neural network algorithms to generate an inmediate result. Then this result,along with contextual information like geolocation, date and time, is sent to a cloud server where it can be used for real time disease tracking. | $1.9M / Seed / Mar 24, 2019 | |
Enzyme
|
Enzyme is building software to help life sciences companies with FDA approval and regulatory compliance. Using Enzyme’s software, those companies can avoid spending money on costly consultants which in turn can reduce their compliance costs by up to 50 percent. Since 10 percent of all personnel in biopharma and life sciences companies are relatedto regulatory issues, it can lower headcount as well. Perhaps most importantly, Enzyme can also make it easier and faster for those companies to bring their products to market. | $1.9M / Seed / Oct 10, 2017 | |
Torch
|
Torch is a leadership development platform with integrated coaching, software, and feedback to raise high performers to the next level. It was founded by a team of executive coaches and experienced psychologists who are passionate about helping senior leaders perform at their highest level.Torch is on a mission to empower leaders to build highgrowth, high-performance cultures by building the awareness and skills required to manage and lead effectively.Our proven model blends human intelligence and digital technology to accelerate talent development and deliver measurable leadership outcomes. | $2.4M / Seed / Oct 04, 2017 | |
Validere
|
Validere is a measurement, reporting, and verification (MRV) SaaS company that helps energy organizations transform disconnected, incomplete emissions data into clear and immediately actionable pathways to financial and environmental value. Modernize your carbon tracking and reporting with an emissions management platform built by industry experts. | $2M / Seed / Sep 07, 2016 | |
Vetcove
|
Vetcove is like Kayak.com for veterinary hospitals to order their supplies. We aggregate the catalogs of all veterinary suppliers across the country, resulting in the largest veterinary catalog in the world, spanning more than 200,000 skus and 2,100 manufacturers. Clinics search one unified catalog with rich content, compare pricing and what'sin stock, and order in one place. Manufacturers, compounding pharmacies, and diagnostic laboratories manage their own product listings, receive payments, and offer free samples. For the first time ever, veterinarians and their staff can use collective insights to discover new products, buy smarter, and advance their practice of veterinary medicine. Our goal is to help vet hospitals operate profitably and assist them in providing the best possible products and services to pets and their pet parents. | $3M / Seed / Aug 22, 2016 | |
|
Vetcove
|
Vetcove is like Kayak.com for veterinary hospitals to order their supplies. We aggregate the catalogs of all veterinary suppliers across the country, resulting in the largest veterinary catalog in the world, spanning more than 200,000 skus and 2,100 manufacturers. Clinics search one unified catalog with rich content, compare pricing and what'sin stock, and order in one place. Manufacturers, compounding pharmacies, and diagnostic laboratories manage their own product listings, receive payments, and offer free samples. For the first time ever, veterinarians and their staff can use collective insights to discover new products, buy smarter, and advance their practice of veterinary medicine. Our goal is to help vet hospitals operate profitably and assist them in providing the best possible products and services to pets and their pet parents. | $3M / Pre-Seed / Aug 22, 2016 |
Co-Investors
About Transcripta Bio
Transcripta Bio is a company dedicated to drug discovery, with a focus on numerous diseases at once, at a never-before-seen pace and scale, with lesser risk and greater assurance.
Transcripta Bio Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Christopher Moxham
Founder, CEO and Chief Scientific Officer
|
|||
|
Elizabeth Iorns
Scientific Founder & Advisor
|
|||
3 more contacts available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Elizabeth Iorns invest in?
Elizabeth Iorns invests primarily in Software, SaaS and Health Care startups, most often at Seed and Pre-Seed stage. Most of the 6 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Elizabeth Iorns's check size?
Elizabeth Iorns typically joins rounds of $1.9M–$3M at Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Elizabeth Iorns participates in.
When did Elizabeth Iorns last invest?
The most recent investment recorded for Elizabeth Iorns closed in Mar 2019. Shizune tracks 6 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
